His main research concerns Colorectal cancer, Cancer research, Pathology, Internal medicine and KRAS. Andreas Jung has included themes like Stem cell and Adenocarcinoma in his Colorectal cancer study. His Cancer research study integrates concerns from other disciplines, such as Beta-catenin, Wnt signaling pathway, Catenin, Metastasis and Tumor progression.
He works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Proportional hazards model. His studies deal with areas such as Cetuximab, Epidermal growth factor receptor and Genetic testing as well as KRAS. His Cetuximab research is multidisciplinary, incorporating perspectives in Bevacizumab and Irinotecan, FOLFIRI.
His primary areas of investigation include Colorectal cancer, Internal medicine, Oncology, Cancer research and KRAS. Andreas Jung focuses mostly in the field of Colorectal cancer, narrowing it down to matters related to Pathology and, in some cases, Adenocarcinoma. Andreas Jung has researched Oncology in several fields, including Proportional hazards model, Biomarker, Oxaliplatin and Microsatellite instability.
His work carried out in the field of Cancer research brings together such families of science as Cancer, Tumor progression and Beta-catenin, Wnt signaling pathway, Catenin. His Catenin research is multidisciplinary, incorporating elements of Tumor suppressor gene and Gene expression. His KRAS study combines topics from a wide range of disciplines, such as Capecitabine and Exon.
Andreas Jung focuses on Internal medicine, Oncology, Colorectal cancer, Bevacizumab and KRAS. His research integrates issues of Personalized medicine and Microsatellite instability in his study of Internal medicine. His Oncology study incorporates themes from Biomarker, Targeted therapy, Neuroblastoma RAS viral oncogene homolog and First line.
His studies in Colorectal cancer integrate themes in fields like Cancer research, MAPK/ERK pathway and Hazard ratio. The study incorporates disciplines such as Cancer, Cancer stem cell, Stem cell, Wnt signaling pathway and Exon in addition to Cancer research. His research in KRAS tackles topics such as Adenocarcinoma which are related to areas like Pathology, Surgical pathology, Adenoma and Allele frequency.
His primary scientific interests are in Colorectal cancer, Internal medicine, Oncology, Cancer research and KRAS. His research in Oncology intersects with topics in Mutation testing and External quality assessment. His work deals with themes such as Cancer, Cancer stem cell, Stem cell, Wnt signaling pathway and MAPK/ERK pathway, which intersect with Cancer research.
His KRAS research integrates issues from Pathology, Gemcitabine, Pancreatic cancer and Adenocarcinoma. The T790M research Andreas Jung does as part of his general Pathology study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science. His study in Bevacizumab is interdisciplinary in nature, drawing from both Cetuximab, Randomized controlled trial and Irinotecan, FOLFIRI.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Hiroki Kato;Osamu Takeuchi;Shintaro Sato;Mitsutoshi Yoneyama.
5'-Triphosphate RNA Is the Ligand for RIG-I
Veit Hornung;Jana Ellegast;Sarah Kim;Krzysztof Brzózka.
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
Volker Heinemann;Ludwig Fischer von Weikersthal;Thomas Decker;Alexander Kiani.
Lancet Oncology (2014)
Migrating cancer stem cells — an integrated concept of malignant tumour progression
Thomas Brabletz;Andreas Jung;Simone Spaderna;Falk Hlubek.
Nature Reviews Cancer (2005)
Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment
Thomas Brabletz;Andreas Jung;Simone Reu;Marc Porzner.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
Marco Tartaglia;Charlotte M Niemeyer;Alessandra Fragale;Alessandra Fragale;Xiaoling Song.
Nature Genetics (2003)
β-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer
Thomas Brabletz;Andreas Jung;Serpil Dag;Falk Hlubek.
American Journal of Pathology (1999)
Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin
Thomas Brabletz;Falk Hlubek;Simone Spaderna;Otto Schmalhofer.
Cells Tissues Organs (2005)
The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer
Simone Spaderna;Otto Schmalhofer;Mandy Wahlbuhl;Arno Dimmler.
Cancer Research (2008)
High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer
Johan Forssell;Åke Öberg;Maria L. Henriksson;Roger Stenling.
Clinical Cancer Research (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: